In a mice model of pulmonary fibrosis, intervention with ISE II was found to ameliorate lung inflammation and lung coefficient induced by BLM, while also reducing the expression levels of M2 macrophage marker CD206, as well as α-SMA, fibronectin, and collagen I in lung tissue [278]. The gene discussed is MRC1; the disease is inflammatory response.